BPIQ-AI · October–November 2026 Report
Phase 2/3 Probability & Move Analysis
If you invest in smid-cap biopharma, these upcoming FDA decisions need to be on your radar. Get BPIQ-AI's probability and stock move analysis for every Oct–Nov PDUFA, free.
Probability and move ranges:
AI-predicted probability and price-move ranges for 16 upcoming October–November PDUFA decisions, across three outcomes (Clean+, Mixed, Clean−)
Timing and hedge fund holders:
Expected readout timing for every catalyst, plus the number of BPIQ-tracked hedge funds holding each stock
Suspected Big Mover flags:
SBM when our model shows a 20%+ stock move in either direction. Six of the 20 readouts are flagged this cycle
Clean+ is a market-outcome probability, not simply the chance a company calls its results ‘positive.’
Clean+ is a market-outcome probability, not simply the chance a company calls its results ‘positive.’
For informational purposes only. This is NOT investment advice. Our models are still being refined. Use this as one part of your own research, or consult a registered professional before trading.
Get the Full Oct–Nov
Readout Table Now!
THE BIG TAKEAWAY
A high probability of positive data does not mean a high probability of a positive stock move.
In this cycle, the highest-probability readouts often carry the least upside, while the biggest potential moves come with the biggest downside risk.
20
readouts
16
companies
6
SBM flags
See what BPIQ users are saying
Get Biotech Stocks To Watch Delivered To You Instantly
What’s inside the report?
STOCKS TO WATCH
Get stocks that are showing high volatility, poised to move.
CATALYST DETAILS
See the drug, date, and more details about each event.
DEEPER ANALYSIS
Get deeper insights into a few stocks catalyst event.
VARIETY OF INDICATIONS
These stocks are in a range of indications allowing you to find opportunities that fit your criteria.